Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Givlaari™ (givosiran) for the Treatment of Acute Hepatic Porphyria
The drug is available in 189mg / mL strength in a single-dose vial for subcutaneous administration. Credit: Business Wire.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Experic
Experic is a contract manufacturing organization (CMO) and pharmaceutical supply...
About
Experic is a contract manufacturing organization (CMO) and pharmaceutical supply services company, which supports all stages of a product’s lifecycle from clinical to commercial scale.
FollowMake an Enquiry
-
esqLABS
Founded in 2017, esqLABS provides platform technologies, software, consulting and...
About
Founded in 2017, esqLABS provides platform technologies, software, consulting and workshops for data analysis and model-based decision support throughout the healthcare industry.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry